Literature DB >> 28108997

Risk of high-grade precancerous lesions and invasive cancers in high-risk HPV-positive women with normal cervix or CIN 1 at baseline-A population-based cohort study.

Srabani Mittal1, Partha Basu2, Richard Muwonge2, Dipanwita Banerjee1, Ishita Ghosh1, Mitali Mukherjee Sengupta1, Pradip Das1, Priatosh Dey1, Ranajit Mandal1, Chinmay Panda1, Jaydip Biswas1, Rengaswamy Sankaranarayanan2.   

Abstract

Infection with high-risk human papillomavirus (HR-HPV) is transient and clears on its own in majority of the women. Only a few women who have persistent infection may finally develop cervical intraepithelial neoplasia (CIN) or cervical cancer in later years. The risk of progression in the HR-HPV-positive women with normal cervix or low-grade lesion on colposcopy and histopathology at baseline is less studied. We performed a longitudinal study on 650 HR-HPV-positive women with colposcopy and/or histopathology-proved normal or CIN1 diagnosis at baseline to assess the cumulative risk of development of high-grade CIN. After a mean follow-up of 2.1 person years of observation (PYO) (range 0.1-5.1), the cumulative incidence of CIN2+ (6.4%; 3.0/100 PYO) was significantly higher in women who had persistent HR-HPV infection compared to those who cleared the infection (adjusted HR 6.28; 95% CI 2.87-13.73). The risk of viral persistence in women aged 50-60 years was two times higher compared to women aged 40-49 years and three times higher compared to women aged 30-39 years. The probability of having persistent infection increased progressively with higher viral load at baseline (adjusted HR 3.29, 95% CI 2.21-4.90 for RLU ≥100; adjusted HR 2.69, 95% CI 1.71-4.22 for RLU 10-100). Women with increasing viral load at follow-up had four times higher risk of developing CIN2 or worse lesions as compared to those with decreasing load (20.9% vs 4.8%; p < 0.001). In the context of developing countries where cytology or genotyping triaging is not feasible, colposcopy referral of HR-HPV-positive women with advancing age, viral persistence, and increasing viral load may be considered.
© 2017 UICC.

Entities:  

Keywords:  cervical intraepithelial neoplasia; cumulative risk; high-risk human papillomavirus; hybrid capture II; viral load

Mesh:

Year:  2017        PMID: 28108997     DOI: 10.1002/ijc.30609

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Association of HPV16 and 18 genomic copies with histological grades of cervical lesions.

Authors:  Negar Joharinia; Ali Farhadi; Seyed Younes Hosseini; Akbar Safaei; Jamal Sarvari
Journal:  Virusdisease       Date:  2019-07-22

Review 2.  Human papillomavirus infection, cervical cancer and the less explored role of trace elements.

Authors:  Anne Boyina Sravani; Vivek Ghate; Shaila Lewis
Journal:  Biol Trace Elem Res       Date:  2022-04-25       Impact factor: 3.738

3.  Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology.

Authors:  Inger Gustavsson; Riina Aarnio; Malin Berggrund; Julia Hedlund-Lindberg; Ann-Sofi Strand; Karin Sanner; Ingrid Wikström; Stefan Enroth; Matts Olovsson; Ulf Gyllensten
Journal:  Br J Cancer       Date:  2018-02-13       Impact factor: 7.640

4.  Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.

Authors:  Riina Aarnio; Ellinor Östensson; Matts Olovsson; Inger Gustavsson; Ulf Gyllensten
Journal:  BMC Cancer       Date:  2020-07-13       Impact factor: 4.430

5.  Diagnostic excision of the cervix in women over 40 years with human papilloma virus persistency and normal cytology.

Authors:  Riina Aarnio; Ingrid Wikström; Inger Gustavsson; Ulf Gyllensten; Matts Olovsson
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-08

6.  Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.

Authors:  Yuejie Li; Jie Liu; Li Gong; Xingwang Sun; Wenbo Long
Journal:  Virol J       Date:  2019-10-16       Impact factor: 4.099

Review 7.  The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.

Authors:  Giovanni Barillari; Paolo Monini; Cecilia Sgadari; Barbara Ensoli
Journal:  Int J Mol Sci       Date:  2018-05-09       Impact factor: 5.923

8.  Characterization of JAK2 V617F (1849 G > T) Mutation in Cervical Cancer Related to Human Papillomavirus and Sexually Transmitted Infections.

Authors:  Masoumeh Abdolmaleki; Amir Sohrabi
Journal:  J Cancer Prev       Date:  2018-06-30

9.  Multiple HPV Infections and Viral Load Association in Persistent Cervical Lesions in Mexican Women.

Authors:  Mariel A Oyervides-Muñoz; Antonio A Pérez-Maya; Celia N Sánchez-Domínguez; Anais Berlanga-Garza; Mauro Antonio-Macedo; Lezmes D Valdéz-Chapa; Ricardo M Cerda-Flores; Victor Trevino; Hugo A Barrera-Saldaña; María L Garza-Rodríguez
Journal:  Viruses       Date:  2020-03-31       Impact factor: 5.048

10.  Prevalence of human papillomavirus among Wenzhou women diagnosed with cervical intraepithelial neoplasia and cervical cancer.

Authors:  Chanqiong Zhang; Chongan Huang; Xiang Zheng; Dan Pan
Journal:  Infect Agent Cancer       Date:  2018-11-26       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.